Kamil Ali-Jackson | Chief Legal Officer |
Neal Walker | President and Chief Executive Officer |
David Gordon | Chief Medical Officer |
Frank Ruffo | Chief Financial Officer |
Louise Chen | Cantor |
Dylan Dupuis | SVB Leerink |
Ladies and gentlemen, thank you for standing by, and welcome to the Third Quarter 2019 Aclaris Therapeutics Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Kamil Ali-Jackson.